Michigan State University is a clinical research site located in East Lansing, Michigan, United States 48823.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Michigan State University has participated in 206 clinical trials with 70 currently active.
Therapeutic areas: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Sponsors: Children's Oncology Group, Biogen, Michigan State University.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Michigan State University has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Michigan State University has 206 clinical trials on record, with 70 currently active. Their work covers B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Michigan State University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.